Alnylam Pharmaceuticals
ALNY
#651
Rank
โ‚น3.728 T
Marketcap
โ‚น27,924
Share price
0.68%
Change (1 day)
22.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company